News
a randomized trial assessing the efficacy and safety of a closed-loop system (Control-IQ, Tandem Diabetes Care) as compared with a sensor-augmented pump. This closed-loop system uses an algorithm ...
Sensor glucose measurements were available during 96% of the follow-up period in the closed-loop group and 92% of the follow-up period in the control group (P=0.01). The closed-loop system was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results